Horizon Therapeutics PLC (NASDAQ:HZNP)

22.81
Delayed Data
As of Jun 14
 -0.79 / -3.35%
Today’s Change
15.92
Today|||52-Week Range
29.44
+16.73%
Year-to-Date
No recent news for Horizon Therapeutics PLC.

Today’s Trading

Previous close23.60
Today’s open23.55
Day’s range22.77 - 23.68
Volume1,202,249
Average volume (3 months)1,863,897
Market cap$4.2B
Data as of 4:00pm ET, 06/14/2019

Growth & Valuation

Earnings growth (last year)+82.28%
Earnings growth (this year)-4.92%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+14.33%
P/E ratio87.7
Price/Sales2.69
Price/Book3.65

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...+1.26+1.38%
GRFSGrifols SA-0.29-1.48%
HCMHutchison China Medi...-0.74-2.74%
RGENRepligen Corp-0.76-1.01%
Data as of 4:00pm ET, 06/14/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)$0.39
Annual revenue (last year)$1.2B
Annual profit (last year)-$74.2M
Net profit margin-6.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Timothy P. Walbert
Senior VP-Business Operations &
Government Affairs
Robert W. Metz
Corporate headquarters
Dublin, Dublin

Forecasts